Nantes University Hospital
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)
Completed
- Conditions
- Acute Respiratory Distress Syndrome (ARDS)Cardiac ArrestCardiogenic Shock
- First Posted Date
- 2020-09-14
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT04548739
- Locations
- 🇫🇷
AP-HP Necker Hospital, Paris, France
🇫🇷AP-HP Trousseau Hospital, Paris, France
🇫🇷CHU de Nantes, Nantes, France
SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications
Completed
- Conditions
- Thrombotic PatientsImpact of Treatment With Cytoreducing AgentDiagnosis of Myeloproliferative Neoplasia
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 253
- Registration Number
- NCT04539678
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels
Recruiting
- Conditions
- Venous ThromboembolismAtrial FibrillationAnticoagulation
- Interventions
- Diagnostic Test: Estimated anticoagulant level (conversion factor x anti-Xa activity)
- First Posted Date
- 2020-09-04
- Last Posted Date
- 2024-05-07
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 2100
- Registration Number
- NCT04539301
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
MICRA - Pilot Study
Not Applicable
Completed
- Conditions
- Rejection Lung Transplant
- Interventions
- Procedure: microscopy confocal
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT04536883
- Locations
- 🇫🇷
CHU Nantes, Nantes, France
Efficacy of a Multi-faceted Intervention Combining an Educational Outreach Visit to General Practitioners and Patient Education Material to Deprescribe Proton Pump Inhibitors (PPI): a Population-based, Pragmatic, Cluster-randomized Controlled Trial
Not Applicable
Completed
- Conditions
- DeprescriptionProton Pump Inhibitors
- Interventions
- Other: GP will receive the educational outreach visit by a DAM (healthcare representative).Other: Patient education material on PPI deprescribing will be sent to the patients
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 25000
- Registration Number
- NCT04513834
- Locations
- 🇫🇷
University Hospital, Nantes, France
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
Phase 4
Completed
- Conditions
- Pancreas TransplantationDiabetesKidney Transplantation
- Interventions
- First Posted Date
- 2020-08-03
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT04496401
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, France
Verification of the Safety of Normal Food Before a Cerebral Arteriography
Recruiting
- Conditions
- Cerebral Angiography
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2021-09-13
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 1000
- Registration Number
- NCT04477031
- Locations
- 🇫🇷
CHU de Nantes, Nantes, France
Safety and Effectiveness Assessment of the MakAir Artificial Ventilator
Not Applicable
Terminated
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- Device: MakAir
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2021-12-29
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 4
- Registration Number
- NCT04475185
- Locations
- 🇫🇷
CHRU Brest, Brest, Finistère, France
🇫🇷CHU Nantes, Nantes, Loire-Atlantique, France
Endothelial Dysfunction in Reversible Cerebral Vasoconstriction Syndrome
Completed
- Conditions
- Reversible Cerebral Vasoconstriction Syndrome
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 62
- Registration Number
- NCT04463212
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia
- First Posted Date
- 2020-07-01
- Last Posted Date
- 2022-03-25
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 416
- Registration Number
- NCT04453384
- Locations
- 🇫🇷
CH de La Rochelle, La Rochelle, France
🇫🇷CHRU Lille, Lille, France
🇫🇷CHU Reims, Reims, France
© Copyright 2025. All Rights Reserved by MedPath